Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency

Journal of Virology

Volumn 76, Issue 17, 2002, Pages 8776-8786

  Kutsch, Olaf ^a   Benveniste, Etty N ^a   Shaw, George M ^a   Levy, David N ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN;

ARTICLE; CELL POPULATION; COMET ASSAY; DNA METHYLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERMINAL REPEAT; MEMORY CELL; PRIORITY JOURNAL; REPORTER GENE; TRANSCRIPTION REGULATION; VIRUS EXPRESSION; VIRUS LATENCY; VIRUS REACTIVATION;

CELL CYCLE; CELL LINE, TRANSFORMED; FLOW CYTOMETRY; FLUOROMETRY; GREEN FLUORESCENT PROTEINS; HIV-1; HUMANS; JURKAT CELLS; LUMINESCENT PROTEINS; MACROPHAGES; MICROSCOPY, FLUORESCENCE; MONOCYTES; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 0036337415     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.17.8776-8786.2002     Document Type: Article

References (56)

1. Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecule-1 expression by HL-60 human promyelocytic leukemia cells in vitro
2. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone
3. Human immunodeficiency virus type 1 provirus is demonstrated in peripheral blood monocytes in vivo: A study utilizing an in situ polymerase chain reaction
4. Inactivation of the HIV LTR by DNA CpG methylation: Evidence for a role in latency
5. Methylation as a modulator of expression of human immunodeficiency virus
6. Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat
7. Interferon-γ induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells
8. Generation of HIV latency during thymopoiesis
9. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection
10. + cell model of chronic infection
11. Human immunodeficiency virus type 1 RNA expression by four chronically infected cell lines indicates multiple mechanisms of latency
12. Inhibition of HIV-1 replication and reactivation from latency by tat transdominant negative mutants in the cysteine rich region
13. CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef
14. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
15. Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy
16. Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection
17. Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy
18. In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency
19. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
20. An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1
21. Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones
22. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-KB sites in the long terminal repeat
23. HIV-1 regulatory/accessory genes: Keys to unraveling viral and host cell biology
24. Mutations in the tat gene are responsible for human immunodeficiency virus type 1 postintegration latency in the U1 cell line
25. A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency
26. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
27. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
28. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line
29. Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate
30. Extracellular Nef protein regulates productive HIV-1 infection from latency
31. Ciprofloxacin inhibits activation of latent human immunodeficiency virus type 1 in chronically infected promonocytic U1 cells
32. Activation of HIV gene expression during monocyte differentiation by induction of NF-KB
33. Repression of HIV-1 transcription by a cellular protein
34. Role of protein kinase C-beta isozyme in activation of latent human immunodeficiency virus type 1 in promonocytic U1 cells by phorbol-12-myristate acetate
35. Activation of the HIV-1 long terminal repeat by cytokines and environmental stress requires an active CSBP/p38 MAP kinase
36. Sodium butyrate treatment of cells latently infected with HIV-1 results in the expression of unspliced viral RNA
37. HIV-1 in human alveolar macrophages from infected patients is latent in vivo but replicates after in vitro stimulation
38. Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1
39. Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency
40. HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltrans-ferases to the viral promoter
41. Activation of infectious virus from latent human immunodeficiency virus infection of monocytes in vivo
42. Inhibition of replication of reactivated human immunodeficiency virus type 1 (HIV-1) in latently infected U1 cells transduced with an HIV-1 long terminal repeat-driven PKR cDNA construct
43. Association of alterations in NF-KB moieties with HIV type 1 proviral latency in certain monocytic cells
44. An HIV-1-infected T cell clone defective in IL-2 production and Ca2+ mobilization after CD3 stimulation
45. Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1
46. Reservoirs for HIV-1: Mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy
47. Efficient replication of human immunodeficiency virus type 1 requires a threshold level of Rev: Potential implications for latency
48. Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: A molecular model for latency
49. The cAMP-dependent protein kinase A and protein kinase C-beta pathways synergistically interact to activate HIV-1 transcription in latently infected cells of monocyte/macrophage lineage
50. Transcription of HIV1 is inhibited by DNA methylation
51. Histone acetyltransferases regulate HIV-1 enhancer activity in vitro
52. Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy
53. Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation
54. HIV-1 latency due to the site of proviral integration
55. Inhibition of HIV-1 latency reactivation by dehydroepiandrosterone (DHEA) and an analog of DHEA
56. ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-κB